A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications

Abstract The effectiveness of nanoparticles (NP) in nanomedicine depends on their ability to extravasate from vasculature towards the target tissue. This is determined by their permeability across the endothelial barrier. Unfortunately, a quantitative study of the diffusion permeability coefficients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yan Teck Ho, Giulia Adriani, Sebastian Beyer, Phan-Thien Nhan, Roger D. Kamm, James Chen Yong Kah
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6e0f5d2ae4834e9e8112c4f27b90b1d4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6e0f5d2ae4834e9e8112c4f27b90b1d4
record_format dspace
spelling oai:doaj.org-article:6e0f5d2ae4834e9e8112c4f27b90b1d42021-12-02T16:06:46ZA Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications10.1038/s41598-017-00750-32045-2322https://doaj.org/article/6e0f5d2ae4834e9e8112c4f27b90b1d42017-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00750-3https://doaj.org/toc/2045-2322Abstract The effectiveness of nanoparticles (NP) in nanomedicine depends on their ability to extravasate from vasculature towards the target tissue. This is determined by their permeability across the endothelial barrier. Unfortunately, a quantitative study of the diffusion permeability coefficients (Pd) of NPs is difficult with in vivo models. Here, we utilize a relevant model of vascular-tissue interface with tunable endothelial permeability in vitro based on microfluidics. Human umbilical vein endothelial cells (HUVECs) grown in microfluidic devices were treated with Angiopoietin 1 and cyclic adenosine monophosphate (cAMP) to vary the Pd of the HUVECs monolayer towards fluorescent polystyrene NPs (pNPs) of different sizes, which was determined from image analysis of their fluorescence intensity when diffusing across the monolayer. Using 70 kDa dextran as a probe, untreated HUVECs yielded a Pd that approximated tumor vasculature while HUVECs treated with 25 μg/mL cAMP had Pd that approximated healthy vasculature in vivo. As the size of pNPs increased, its Pd decreased in tumor vasculature, but remained largely unchanged in healthy vasculature, demonstrating a trend similar to tumor selectivity for smaller NPs. This microfluidic model of vascular-tissue interface can be used in any laboratory to perform quantitative assessment of the tumor selectivity of nanomedicine-based systems.Yan Teck HoGiulia AdrianiSebastian BeyerPhan-Thien NhanRoger D. KammJames Chen Yong KahNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yan Teck Ho
Giulia Adriani
Sebastian Beyer
Phan-Thien Nhan
Roger D. Kamm
James Chen Yong Kah
A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications
description Abstract The effectiveness of nanoparticles (NP) in nanomedicine depends on their ability to extravasate from vasculature towards the target tissue. This is determined by their permeability across the endothelial barrier. Unfortunately, a quantitative study of the diffusion permeability coefficients (Pd) of NPs is difficult with in vivo models. Here, we utilize a relevant model of vascular-tissue interface with tunable endothelial permeability in vitro based on microfluidics. Human umbilical vein endothelial cells (HUVECs) grown in microfluidic devices were treated with Angiopoietin 1 and cyclic adenosine monophosphate (cAMP) to vary the Pd of the HUVECs monolayer towards fluorescent polystyrene NPs (pNPs) of different sizes, which was determined from image analysis of their fluorescence intensity when diffusing across the monolayer. Using 70 kDa dextran as a probe, untreated HUVECs yielded a Pd that approximated tumor vasculature while HUVECs treated with 25 μg/mL cAMP had Pd that approximated healthy vasculature in vivo. As the size of pNPs increased, its Pd decreased in tumor vasculature, but remained largely unchanged in healthy vasculature, demonstrating a trend similar to tumor selectivity for smaller NPs. This microfluidic model of vascular-tissue interface can be used in any laboratory to perform quantitative assessment of the tumor selectivity of nanomedicine-based systems.
format article
author Yan Teck Ho
Giulia Adriani
Sebastian Beyer
Phan-Thien Nhan
Roger D. Kamm
James Chen Yong Kah
author_facet Yan Teck Ho
Giulia Adriani
Sebastian Beyer
Phan-Thien Nhan
Roger D. Kamm
James Chen Yong Kah
author_sort Yan Teck Ho
title A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications
title_short A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications
title_full A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications
title_fullStr A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications
title_full_unstemmed A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications
title_sort facile method to probe the vascular permeability of nanoparticles in nanomedicine applications
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/6e0f5d2ae4834e9e8112c4f27b90b1d4
work_keys_str_mv AT yanteckho afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT giuliaadriani afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT sebastianbeyer afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT phanthiennhan afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT rogerdkamm afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT jameschenyongkah afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT yanteckho facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT giuliaadriani facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT sebastianbeyer facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT phanthiennhan facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT rogerdkamm facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
AT jameschenyongkah facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications
_version_ 1718384846109147136